chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Facial paralysis, Mastication disorder, Muscle disorder, Ophthalmoplegia, Pain in extremity
Clinical narrative: Narrative:  72 yo M with a history of hypertension, hyperlipidemia and CHADS2 paroxysmal atrial fibrillation with a history of med noncompliance. On Friday, 02/12/2021, patient received his 1st Pfizer COVID-19 vaccine.  On Monday, 02/22/2021, patient called the Telephone Care Program (TCP). Per the TCP note, FEB 12- first Pfizer vaccine, no issues except sore arm and then Thursday lost control of the muscles in his face" and "he can not close his left eye and his left side of his face is paralyzed or  drooping as well. He said he did not call the for advise days ago because he read on the internet that it would go away in 5 days. Now he is concerned because it has not gone away." Patient initially reluctant to present to hospital because he thought nothing could be done and wanted to continue on with the second COVID-19 vaccine dose. He received his second COVID-19 vaccine on 03/05/2021. Per 3/8/21 primary care sameday appointment, patient reported that he couldn't open left eye. Diagnosed with Bell's palsy secondary to COVID vaccination. Low suspicion for CVA (No difficulty swallowing but difficulty chewing. No problems with speech,  no headache, no doubled/blurred vision, no tinnitus, difficulty with sound, no numbness or tingling in the upper extremities, loss of smell, no confusion, and no balancing difficulties.) He was recommended to wear an eye patch and use artificial tears. Per 5/3/21 visit with his primary care provider, chiropractic consult, the patient has had some improvement with his Bell's Palsy symptoms.  "...he states he has had improvement: 50% in the forehead, 20% with cheeks and facial, 50% with mouth movements. He denies any changes with closing his left eyelid. He states he has noticed that he is unable to open his right eye while the  left eye is manually shut.; Per the 6/25/21, acupuncture/chiro follow up note, the patient, "presents with 0/10 face pain, he is now able to wink though not yet able to move orbicularis oris." Per 7/23/21 acupuncture/chiro follow up note, "He is able to demonstrate full function of the left eye though still has issue with drinking and droll out of the mouth."
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  73yo male pt had received covid vaccinations on 2/4/21 & 3/5/21. Pt with hx of leukemia in palliative care post chemotherapy. Pt died at HOSPITAL on 7/2/2021. Likely death is unrelated to covid vaccinations.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Lung disorder
Clinical narrative: Narrative:  70yo male in need of lung transplant died on 7/2/21 at hospital. Pt had received covid EAU vaccinations on 2/12/21 & 3/17/21. It appears death is unrelated to covid vaccinations.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Narrative: Patient came to walk-in clinic for COVID vaccine. After Janssen vaccine was administered, the nurse discovered information in the chart that he had previously received this vaccine May 2021. The patient denies recollection of this prior dose. The patient was monitored, and no adverse reaction was noted.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  94yo male died on 6/15/2021. Pt resided in nursing facility. Pt had received covid vaccine on 1/14/2021. No information in database system about pt's death. Likely death not related to vaccinations given pt's advanced age & 6 months between vaccination & death.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  80yo male with hx of Multiple Myeloma treated at facility outside of our facility died at home on 6/29/2021. Pt had received covid-19 vaccines EUA on 2/1/21 & 3/9/2021. Appears death is not related to vaccinations.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient received dose on of Moderna on 2/16/21, second dose received 3/16/21; COVID negative 4/29/21;COVID positive 7/3/21 and 7/9/21;
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Gastrointestinal haemorrhage
Clinical narrative: Narrative:  Pt admitted to hospice 3/8/21 for GI bleed. Death within 42 days of covid vaccination
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Exposure to SARS-CoV-2, Fatigue
Clinical narrative: Narrative: COVID infection after completion of COVID vaccine series: 01/26/2021 COVID vaccine dose #1 02/17/2021 COVID vaccine dose#2 07/09/2021 Pt presented to front of VA c/o fatigue and loss of taste/smell. Stated wife had dx of COVID on 07/07/2021 and admitted to facility for tx. 07/09/2021 COVID positive per nasopharyngeal swab (as ordered based on COVID positive screening tool). 07/10/2021 Pt reported continued feelings of fatigue. 07/11/2021 Pt reported continued feelings of fatigue. 07/12/2021 Pt reported resolution of symptoms.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection after completion of COVID vaccine series: 01/26/2021 COVID vaccine dose #1 02/17/2021 COVID vaccine dose#2 07/09/2021 Pt presented to front of VA c/o fatigue and loss of taste/smell. Stated wife had dx of COVID on 07/07/2021 and admitted to facility for tx. 07/09/2021 COVID positive per nasopharyngeal swab (as ordered based on COVID positive screening tool). 07/10/2021 Pt reported continued feelings of fatigue. 07/11/2021 Pt reported continued feelings of fatigue. 07/12/2021 Pt reported resolution of symptoms.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Nausea, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection after completion of COVID vaccination series: 01/11/2021 COVID vaccine dose #1 02/08/2021 COVID vaccine dose #2 06/30/2021 Pt reported onset of nausea and slight rhinorrhea 07/09/2021 COVID positive screen indicating need for testing. COVID positive per facility nasopharyngeal swab. 07/10/2021 Clinical resolution of COVID infection.
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatinine increased, Cough, Dyspnoea, Dyspnoea exertional, Exposure to SARS-CoV-2
Clinical narrative: Narrative:  Patient presented with complaints of fever/fatigue/cough/shortness of breath. -Patient has been having several COVID-19 complaints such as headache, fatigue, cough, shortness of breath particularly on exertion. Symptoms have been occurring for appx 1 week. Patient's longterm partner was recently admitted to Medical Center for PNA which she was found to be COVID19 positive. Patient's partner was having a cough for appx 3-4 weeks and was worsening the last several days. -No complaints of anosmia, loss of appetite, diarrhea, CP, pleuritic CP -Patient had Pfizer COVID19 PNA vaccination in Jan/Feb 2021 -Patient has former tobacco hx 1ppd for 30 years in past and Substance abuse history including cocaine, IV heroin, marijuana Admitted to hospital, administered oxygen and dexamethasone and supportive care. Remdesevir administered once renal functino improved to Cr<1.5. Discharged home after revovering.
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Pyrexia, Renal impairment
Clinical narrative: Narrative:  Patient presented with complaints of fever/fatigue/cough/shortness of breath. -Patient has been having several COVID-19 complaints such as headache, fatigue, cough, shortness of breath particularly on exertion. Symptoms have been occurring for appx 1 week. Patient's longterm partner was recently admitted to Medical Center for PNA which she was found to be COVID19 positive. Patient's partner was having a cough for appx 3-4 weeks and was worsening the last several days. -No complaints of anosmia, loss of appetite, diarrhea, CP, pleuritic CP -Patient had Pfizer COVID19 PNA vaccination in Jan/Feb 2021 -Patient has former tobacco hx 1ppd for 30 years in past and Substance abuse history including cocaine, IV heroin, marijuana Admitted to hospital, administered oxygen and dexamethasone and supportive care. Remdesevir administered once renal functino improved to Cr<1.5. Discharged home after revovering.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Anosmia, COVID-19, Rhinorrhoea, SARS-CoV-2 test positive, Sneezing
Clinical narrative: Narrative:  COVID infection following completion of COVID vaccine series: 12/30/2020 COVID vaccine dose #1 01/20/2021 COVID vaccine dose #2 07/08/2021 Pt presented to ED c/o loss of smell x 7 days and slight rhinorrhea and sneezing. Requested be tested for COVID. 07/08/2021 COVID positive per facility nasopharynx swab 07/10/2021 Pt reported still largely asymptomatic except for loss of smell. 07/12/2021 Pt reported continued loss of smell.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Bacteraemia, COVID-19, Diarrhoea, Lethargy, SARS-CoV-2 test positive
Clinical narrative: Narrative:  73 y/o male with hx of resistant UTI, HTN, HFpEF, DM-2, OA and BPH presents from adult living facility for lethargy. Per ED report patient had vomited prior to admission but on further discussion with patient's adult living facility they reported patient had an episode of diarrhea. Per facility patient was normal in AM of 7/6/21. Reportedly the aide went to check on the patient and found him unresponsive and called EMS. Patient had no complaints prior to this episode. On 7/6/2021 pt's lab reported positive for covid infection. Pt was fully vaccinated at facility on 12/31/2020 & 1/25/2021. Pt was started on Remdesivir & dexamethasone and admitted. By the next day pt's medical team had ruled out covid infection and diagnosed UTI complicated by bacteremia. Appropriate antibiotics were started. Pt was discharged to a skilled care nursing facility with continuation of iv antibiotics on 7/12/2021.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Unresponsive to stimuli, Urinary tract infection, Vomiting
Clinical narrative: Narrative:  73 y/o male with hx of resistant UTI, HTN, HFpEF, DM-2, OA and BPH presents from adult living facility for lethargy. Per ED report patient had vomited prior to admission but on further discussion with patient's adult living facility they reported patient had an episode of diarrhea. Per facility patient was normal in AM of 7/6/21. Reportedly the aide went to check on the patient and found him unresponsive and called EMS. Patient had no complaints prior to this episode. On 7/6/2021 pt's lab reported positive for covid infection. Pt was fully vaccinated at facility on 12/31/2020 & 1/25/2021. Pt was started on Remdesivir & dexamethasone and admitted. By the next day pt's medical team had ruled out covid infection and diagnosed UTI complicated by bacteremia. Appropriate antibiotics were started. Pt was discharged to a skilled care nursing facility with continuation of iv antibiotics on 7/12/2021.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Contraindication to vaccination, Immunisation reaction, Throat irritation, Throat tightness
Clinical narrative: Narrative:  30 min after 1st covid vaccine admin. pt felt scratchy throat and throat closing. Pt sent to ER and required an epi-pen. Dose #2 contraindicated per PCP MD. Chart flagged with ADR to covid vaccine.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Narrative: Developed COVD-19 after full vaccination with 2 doses of Pfizer.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram normal, Extrasystoles, Sinus rhythm
Clinical narrative: Narrative:  seen in walk in clinic, EKG normal but cardiac exam revealed premature beats
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  No other information documented in chart other than patient expired at home 5/15/21 within 42 days of covid vaccination
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Incomplete course of vaccination
Clinical narrative: Narrative:  Patient received Moderna Covid vaccine #1 on 5/14/21. He had two follow up visits with behavioral health on 5/18/21 and 5/19/21. In those notes, he did not report any medical concerns. He was followed by mental health for anxiety, PTSD, alcohol abuse and panic disorder. On 6/11/21, the Covid clinic attempted to contact patient regarding his second vaccine and they were informed by his mother that he had passed away and only information given was that he was found in his truck. Date of death is recorded as 5/29/21, no autopsy reports available. There were 15 days from time of vaccine to date of death.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID-19 infection after full COVID-19  vaccination
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Pt died on 6/1/2021. Pt had janssen one dose covid vaccine on 5/13/2021. No information provided about pt's death provided. Not clear if vaccine was related to pt's death or not. Per most recent provider note (5/24/2021) (endocrine provider) notes pt was a 71yo male with diabetes on insulin & metformin, recent homelessness & sometimes missed meals noted. Also had lost his medications in April 2021 & came to ER to replace them. Most recent med list posted below. Active Outpatient Medications Status 1) ALBUTEROL 90MCG (CFC-F) 200D ORAL INHL INHALE 2 PUFFS ACTIVE BY MOUTH FOUR TIMES A DAY IF NEEDED FOR BREATHING 2) ASPIRIN 81MG EC TAB TAKE ONE TABLET BY MOUTH DAILY ACTIVE 3) ATORVASTATIN CALCIUM 80MG TAB TAKE ONE TABLET BY ACTIVE MOUTH EVERY EVENING FOR CHOLESTEROL 4) BUDESONIDE 80/FORMOTER 4.5MCG 120D INH INHALE 2 BY ACTIVE MOUTH TWICE A DAY SHAKE WELL BEFORE USING, RINSE MOUTH AFTER USE 5) CYANOCOBALAMIN 500MCG TAB TAKE TWO TABLETS BY MOUTH ACTIVE DAILY 6) FERROUS SULFATE 325MG TAB TAKE ONE TABLET BY MOUTH ACTIVE TWICE A DAY WITH MEALS 7) FOLIC ACID 1MG TAB TAKE ONE TABLET BY MOUTH EVERY ACTIVE MORNING 8) INSULIN,DETEMIR 100UNIT/ML FLEXTOUCH 3ML INJECT 18 ACTIVE UNITS UNDER THE SKIN EVERY MORNING AND INJECT 22 UNITS AT BEDTIME 9) LOSARTAN 25MG TAB TAKE ONE TABLET BY MOUTH DAILY FOR ACTIVE BLOOD PRESSURE 10) METFORMIN HCL 1000MG TAB TAKE ONE TABLET BY MOUTH ACTIVE TWICE A DAY WITH MORNING AND EVENING MEAL FOR BLOOD SUGAR 11) NEEDLE,PEN 32G,4MM USE NEEDLE AS DIRECTED FOR INSULIN ACTIVE PEN INJECTIONS 12) SERTRALINE HCL 50MG TAB TAKE THREE TABLETS BY MOUTH ACTIVE EVERY MORNING 13) TIOTROPIUM 2.5MCG/ACTUAT 60D ORAL INHL INHALE 2 PUFFS ACTIVE BY MOUTH DAILY
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cellulitis, SARS-CoV-2 test positive
Clinical narrative: Narrative: This is a 73 yo M patient with PMH of CAD s/p CABG x3 v ,CHF ? EF, Hypothyroidism, Arrhythmia s/p Pacemaker /AICD,BPH , Vit D def, chronic Debility Nursing Home Resident admitted after sent by Cardiologist to ED for COVID + and LLE cellulitis 06/25/2021.He is admitted to COVID Unit and placed on droplet precaution. HOSPITAL COURSE: Patient admitted to hospital for treatment of COVID pneumonia and lower leg cellulitis. Administered antibiotics for cellulitis, Remdesevir and dexamethasone for COVID-19. Patient recovered to baseline and was discharged to a long-term skilled nursing facility.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Ecchymosis, Full blood count normal, Haematoma, Haemorrhage, Platelet count normal
Clinical narrative: Bleeding Narrative:  Employee vaccinated with Triple J on 3/18/2021. On 4/11 developed a hematoma on right inner thigh which burst on 4/12 leaving large ecchymotic areas, about 4 x 6 inches with clearer central area which was the site of the original hematoma. CBC drawn, WNL, PLT = 234.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Balance disorder, Dysarthria, Dysstasia, Grip strength decreased
Clinical narrative: Narrative:  1-2 WEEKS (EXACT DATE OF INITIAL ADVERSE EVENT UNKNOWN)AFTER TAKING JANSSEN VACCINE PT STARTED HAVING DIFFICULTY USING RIGHT ARM AND HAND. THE WEAKNESS PROGRESSED TO BILATERAL LEGS. PT HAS DIFFICULTY RISING FROM CHAIR AND IMBALANCE WITH WALKING, SPEECH IS SLURRED. DECREASED STRENGTH IN RIGHT HAND (GRIPS, WRIST EXTENSION, AND FLEXION), RIGHT BICEP, BILATERAL KNEE EXTENSION, AND RIGHT FOOT DORSIFLEXION.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Muscular weakness, Musculoskeletal disorder
Clinical narrative: Narrative:  1-2 WEEKS (EXACT DATE OF INITIAL ADVERSE EVENT UNKNOWN)AFTER TAKING JANSSEN VACCINE PT STARTED HAVING DIFFICULTY USING RIGHT ARM AND HAND. THE WEAKNESS PROGRESSED TO BILATERAL LEGS. PT HAS DIFFICULTY RISING FROM CHAIR AND IMBALANCE WITH WALKING, SPEECH IS SLURRED. DECREASED STRENGTH IN RIGHT HAND (GRIPS, WRIST EXTENSION, AND FLEXION), RIGHT BICEP, BILATERAL KNEE EXTENSION, AND RIGHT FOOT DORSIFLEXION.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Deep vein thrombosis
Clinical narrative: Narrative: Pt is a 65y male. Died on 07/03/2021. Deputy Coroner contacted the MC and alerted the AOD that patient had been found inside of his home deceased. The cause of death will more than likely be a result of suspected DVT. Vaccine not likely related to cause of death. Pt received covid vaccines on 3/14/21 & 2/14/21.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Pallor, Peripheral coldness, Thrombosis
Clinical narrative: Narrative: Hospital-foot cold and white, blood clots in foot and groin, was advised from covid. Pfizer vaccine x 2
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Blood creatinine increased, Blood potassium increased, Blood urea increased, COVID-19
Clinical narrative: Narrative:  Covid+/pneumonia, mild SOB, poor oral intake, AKI, hx of liver/kidney transplant. Moderna 16/21 and 2/4/21. Hospital course: Patient is a 60 year old male with a PMHx simultaneous liver and kidney transplant on immunosuppressants, CKD, CAD, I-ITN, HLD, and GERD who was admitted to hospital on 11/1/2021 for acute kidney injury, Patient was also noted to be Covid positive, However, he was saturating well on room and stated that his symptoms had started 4 weeks prior, Patient reported receiving 2 doses of Moderna and was scheduled to receive his booster vaccine in the near future, In the ER, lab work revealed a BUN: 99.8, creatinine: 4.81 from a baseline ~2.5-3, K: 6.3. Patient was started on IV fluids, and nephrology was consulted. Creatinine improved with IV fluid administration, Nephrology suspected that AKI was secondary to volume depletion from poor oral intake with recent Covid infection, On day of discharge, patient's creatinine corrected to 3.41.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia, Dyspnoea, Hypophagia, Hypovolaemia, Laboratory test abnormal
Clinical narrative: Narrative:  Covid+/pneumonia, mild SOB, poor oral intake, AKI, hx of liver/kidney transplant. Moderna 16/21 and 2/4/21. Hospital course: Patient is a 60 year old male with a PMHx simultaneous liver and kidney transplant on immunosuppressants, CKD, CAD, I-ITN, HLD, and GERD who was admitted to hospital on 11/1/2021 for acute kidney injury, Patient was also noted to be Covid positive, However, he was saturating well on room and stated that his symptoms had started 4 weeks prior, Patient reported receiving 2 doses of Moderna and was scheduled to receive his booster vaccine in the near future, In the ER, lab work revealed a BUN: 99.8, creatinine: 4.81 from a baseline ~2.5-3, K: 6.3. Patient was started on IV fluids, and nephrology was consulted. Creatinine improved with IV fluid administration, Nephrology suspected that AKI was secondary to volume depletion from poor oral intake with recent Covid infection, On day of discharge, patient's creatinine corrected to 3.41.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Malaise, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Covid+/pneumonia, mild SOB, poor oral intake, AKI, hx of liver/kidney transplant. Moderna 16/21 and 2/4/21. Hospital course: Patient is a 60 year old male with a PMHx simultaneous liver and kidney transplant on immunosuppressants, CKD, CAD, I-ITN, HLD, and GERD who was admitted to hospital on 11/1/2021 for acute kidney injury, Patient was also noted to be Covid positive, However, he was saturating well on room and stated that his symptoms had started 4 weeks prior, Patient reported receiving 2 doses of Moderna and was scheduled to receive his booster vaccine in the near future, In the ER, lab work revealed a BUN: 99.8, creatinine: 4.81 from a baseline ~2.5-3, K: 6.3. Patient was started on IV fluids, and nephrology was consulted. Creatinine improved with IV fluid administration, Nephrology suspected that AKI was secondary to volume depletion from poor oral intake with recent Covid infection, On day of discharge, patient's creatinine corrected to 3.41.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: PATIENT WAS GIVEN 0.2ML OF THE 30MCG FORMULA INSTEAD OF 0.2ML OF THE 10MCG FORMULA,
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: Myalgia Narrative: sore arm for 24hrs
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, Chest pain, Death, Dyspnoea, Pericarditis
Clinical narrative: Episode of pericarditis. Self -treated with ibuprofen. Improve the next day. The following day, symptoms worsened. Chest pain, shortness of breathe, difficulty breathing. Emergency services were call. Suffered cardiac arrest in ambulance in route to hospital.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Autopsy, Cardiac arrest, Chest pain, Condition aggravated, Dyspnoea
Clinical narrative: Episode of pericarditis. Self -treated with ibuprofen. Improve the next day. The following day, symptoms worsened. Chest pain, shortness of breathe, difficulty breathing. Emergency services were call. Suffered cardiac arrest in ambulance in route to hospital.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pericarditis
Clinical narrative: Episode of pericarditis. Self -treated with ibuprofen. Improve the next day. The following day, symptoms worsened. Chest pain, shortness of breathe, difficulty breathing. Emergency services were call. Suffered cardiac arrest in ambulance in route to hospital.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chest X-ray abnormal, Chills
Clinical narrative: Starting 04/02/2021, I developed a fever that lasted about 12 hours and as soon as that went away, my oxygen levels plummeted. My husband drove me to the ER and my oxygen levels were at 60. They gave me 15L oxygen for 10 min and then 5L oxygen for about a day, then 2L of oxygen for 4 days then stopped. I was diagnosed with COVID19 for a second time and Lipid Pneumonia for the 5th time. I was given Remdefivir, Convolescent Plasma and a steroid. After about 6 days, I was able to breath on my own without additional oxygen and was released. I was in the hospital again 3 weeks later (04/24/2021) for Lipid Pneumonia the 6th time and I had an oxygen level of 85. I got a cocktail of antibiotics and a steroid, and was hospitalized for 6 days. I remained on the steroid for 2 months afterwards.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Cough, Hyperhidrosis, Lung opacity, Oxygen saturation decreased
Clinical narrative: Starting 04/02/2021, I developed a fever that lasted about 12 hours and as soon as that went away, my oxygen levels plummeted. My husband drove me to the ER and my oxygen levels were at 60. They gave me 15L oxygen for 10 min and then 5L oxygen for about a day, then 2L of oxygen for 4 days then stopped. I was diagnosed with COVID19 for a second time and Lipid Pneumonia for the 5th time. I was given Remdefivir, Convolescent Plasma and a steroid. After about 6 days, I was able to breath on my own without additional oxygen and was released. I was in the hospital again 3 weeks later (04/24/2021) for Lipid Pneumonia the 6th time and I had an oxygen level of 85. I got a cocktail of antibiotics and a steroid, and was hospitalized for 6 days. I remained on the steroid for 2 months afterwards.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Starting 04/02/2021, I developed a fever that lasted about 12 hours and as soon as that went away, my oxygen levels plummeted. My husband drove me to the ER and my oxygen levels were at 60. They gave me 15L oxygen for 10 min and then 5L oxygen for about a day, then 2L of oxygen for 4 days then stopped. I was diagnosed with COVID19 for a second time and Lipid Pneumonia for the 5th time. I was given Remdefivir, Convolescent Plasma and a steroid. After about 6 days, I was able to breath on my own without additional oxygen and was released. I was in the hospital again 3 weeks later (04/24/2021) for Lipid Pneumonia the 6th time and I had an oxygen level of 85. I got a cocktail of antibiotics and a steroid, and was hospitalized for 6 days. I remained on the steroid for 2 months afterwards.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Bronchoscopy abnormal, COVID-19, Computerised tomogram thorax abnormal, Condition aggravated
Clinical narrative: Starting 04/02/2021, I developed a fever that lasted about 12 hours and as soon as that went away, my oxygen levels plummeted. My husband drove me to the ER and my oxygen levels were at 60. They gave me 15L oxygen for 10 min and then 5L oxygen for about a day, then 2L of oxygen for 4 days then stopped. I was diagnosed with COVID19 for a second time and Lipid Pneumonia for the 5th time. I was given Remdefivir, Convolescent Plasma and a steroid. After about 6 days, I was able to breath on my own without additional oxygen and was released. I was in the hospital again 3 weeks later (04/24/2021) for Lipid Pneumonia the 6th time and I had an oxygen level of 85. I got a cocktail of antibiotics and a steroid, and was hospitalized for 6 days. I remained on the steroid for 2 months afterwards.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test abnormal, Oxygen saturation decreased, Pneumonia, Pneumonia lipoid, Pyrexia
Clinical narrative: Starting 04/02/2021, I developed a fever that lasted about 12 hours and as soon as that went away, my oxygen levels plummeted. My husband drove me to the ER and my oxygen levels were at 60. They gave me 15L oxygen for 10 min and then 5L oxygen for about a day, then 2L of oxygen for 4 days then stopped. I was diagnosed with COVID19 for a second time and Lipid Pneumonia for the 5th time. I was given Remdefivir, Convolescent Plasma and a steroid. After about 6 days, I was able to breath on my own without additional oxygen and was released. I was in the hospital again 3 weeks later (04/24/2021) for Lipid Pneumonia the 6th time and I had an oxygen level of 85. I got a cocktail of antibiotics and a steroid, and was hospitalized for 6 days. I remained on the steroid for 2 months afterwards.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Swallow study
Clinical narrative: Starting 04/02/2021, I developed a fever that lasted about 12 hours and as soon as that went away, my oxygen levels plummeted. My husband drove me to the ER and my oxygen levels were at 60. They gave me 15L oxygen for 10 min and then 5L oxygen for about a day, then 2L of oxygen for 4 days then stopped. I was diagnosed with COVID19 for a second time and Lipid Pneumonia for the 5th time. I was given Remdefivir, Convolescent Plasma and a steroid. After about 6 days, I was able to breath on my own without additional oxygen and was released. I was in the hospital again 3 weeks later (04/24/2021) for Lipid Pneumonia the 6th time and I had an oxygen level of 85. I got a cocktail of antibiotics and a steroid, and was hospitalized for 6 days. I remained on the steroid for 2 months afterwards.
Age: 65.0
Sex: F
Vaccine: COVID19, UNK, COVID19
Symptoms: Blood test, Migraine
Clinical narrative: Daily headaches, trouble concentrating, trouble with brain fog
Age: 65.0
Sex: F
Vaccine: COVID19, UNK, COVID19
Symptoms: Disturbance in attention, Feeling abnormal, Headache, Laboratory test
Clinical narrative: Daily headaches, trouble concentrating, trouble with brain fog
Age: 65.0
Sex: F
Vaccine: COVID19, UNK, COVID19
Symptoms: Headache, Migraine, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Daily headaches, trouble concentrating, trouble with brain fog
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Adverse event, Breast pain, Laboratory test, Lymphadenopathy, Neck mass
Clinical narrative: Some years ago, I had two needle biopsies and an ultrasound of a lump along my jawline. It was diagnosed as cyst filled with necrotic tissue on my salivary gland (my left side). It started as pea-size and grew to marble-size.    After the covid vaccine, I began to notice changes.  The lump on the left was getting bigger - and another pea-size lump was evident on the right jawline.   Over the fall, the left lump has grown to walnut-size. The ovoid left lump has also slipped downward from the jawline. I have had several scary episodes with the left side: choking, unable to breathe; painful to even touch the lump or neck.     Since I am without insurance (homeless), I could find clinics to diagnose, but none would fund anything else. I have an appointment for a soft tissue ultrasound of my neck (after being told months ago by same doctor that the clinic didn't allow it.)
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Choking, Condition aggravated, Dyspnoea, Mammogram, Salivary gland mass
Clinical narrative: Some years ago, I had two needle biopsies and an ultrasound of a lump along my jawline. It was diagnosed as cyst filled with necrotic tissue on my salivary gland (my left side). It started as pea-size and grew to marble-size.    After the covid vaccine, I began to notice changes.  The lump on the left was getting bigger - and another pea-size lump was evident on the right jawline.   Over the fall, the left lump has grown to walnut-size. The ovoid left lump has also slipped downward from the jawline. I have had several scary episodes with the left side: choking, unable to breathe; painful to even touch the lump or neck.     Since I am without insurance (homeless), I could find clinics to diagnose, but none would fund anything else. I have an appointment for a soft tissue ultrasound of my neck (after being told months ago by same doctor that the clinic didn't allow it.)
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tenderness, Ultrasound scan
Clinical narrative: Some years ago, I had two needle biopsies and an ultrasound of a lump along my jawline. It was diagnosed as cyst filled with necrotic tissue on my salivary gland (my left side). It started as pea-size and grew to marble-size.    After the covid vaccine, I began to notice changes.  The lump on the left was getting bigger - and another pea-size lump was evident on the right jawline.   Over the fall, the left lump has grown to walnut-size. The ovoid left lump has also slipped downward from the jawline. I have had several scary episodes with the left side: choking, unable to breathe; painful to even touch the lump or neck.     Since I am without insurance (homeless), I could find clinics to diagnose, but none would fund anything else. I have an appointment for a soft tissue ultrasound of my neck (after being told months ago by same doctor that the clinic didn't allow it.)
Age: 80.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Dysstasia, Muscular weakness
Clinical narrative: could not get out of the bed to move; could not move body had to crawl; This case was reported by a consumer via call center representative and described the occurrence of mobility decreased in a 80-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd September 2021 13:00, the patient received the 1st dose of Shingrix (intramuscular). In September 2021, 12 hrs after receiving Shingrix, the patient experienced mobility decreased and walking difficulty. On 3rd September 2021, the outcome of the mobility decreased was recovered/resolved. On 3rd September 2021 10:00, the outcome of the walking difficulty was recovered/resolved.   It was unknown if the reporter considered the mobility decreased and walking difficulty to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient herself. Patient received her first Shingrix vaccine in the left arm at 1 pm and next day at 1 am she could not get out of the bed to physically move her body.  The patient reported that she had to crawl on the floor to get to the bathroom and then crawl back to bed until 7am and then she crawled to the family room to watch TV until 10am when symptom resolved. The patient did notify the pharmacy where she got the vaccine and her health care professional of what happened. The reporter did  not consent to follow-up.
Age: 80.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Gait disturbance, Mobility decreased
Clinical narrative: could not get out of the bed to move; could not move body had to crawl; This case was reported by a consumer via call center representative and described the occurrence of mobility decreased in a 80-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd September 2021 13:00, the patient received the 1st dose of Shingrix (intramuscular). In September 2021, 12 hrs after receiving Shingrix, the patient experienced mobility decreased and walking difficulty. On 3rd September 2021, the outcome of the mobility decreased was recovered/resolved. On 3rd September 2021 10:00, the outcome of the walking difficulty was recovered/resolved.   It was unknown if the reporter considered the mobility decreased and walking difficulty to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient herself. Patient received her first Shingrix vaccine in the left arm at 1 pm and next day at 1 am she could not get out of the bed to physically move her body.  The patient reported that she had to crawl on the floor to get to the bathroom and then crawl back to bed until 7am and then she crawled to the family room to watch TV until 10am when symptom resolved. The patient did notify the pharmacy where she got the vaccine and her health care professional of what happened. The reporter did  not consent to follow-up.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, Headache, SARS-CoV-2 test positive
Clinical narrative: per death certificate, pt died in the nursing home of ARF and COVID-19
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, COVID-19, Death
Clinical narrative: per death certificate, pt died in the nursing home of ARF and COVID-19
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, COVID-19, COVID-19 pneumonia, Death, Dyspnoea
Clinical narrative: recently discharged from hospital for AHRF secondary to COVID; presented back to hosp with worsening dyspnea; treated with dexamethasone, antibiotics, redesivir; required intubation with mechanical ventilation; increased O2 requirements; pt transitioned to comfort care; she died in the hosp
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Endotracheal intubation, General physical health deterioration, Hypoxia, Intensive care, Jugular vein thrombosis
Clinical narrative: recently discharged from hospital for AHRF secondary to COVID; presented back to hosp with worsening dyspnea; treated with dexamethasone, antibiotics, redesivir; required intubation with mechanical ventilation; increased O2 requirements; pt transitioned to comfort care; she died in the hosp
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mechanical ventilation, SARS-CoV-2 test positive, Subclavian vein thrombosis, Urinary tract infection
Clinical narrative: recently discharged from hospital for AHRF secondary to COVID; presented back to hosp with worsening dyspnea; treated with dexamethasone, antibiotics, redesivir; required intubation with mechanical ventilation; increased O2 requirements; pt transitioned to comfort care; she died in the hosp
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mechanical ventilation, SARS-CoV-2 test, SARS-CoV-2 test positive, Subclavian vein thrombosis, Urinary tract infection
Clinical narrative: recently discharged from hospital for AHRF secondary to COVID; presented back to hosp with worsening dyspnea; treated with dexamethasone, antibiotics, redesivir; required intubation with mechanical ventilation; increased O2 requirements; pt transitioned to comfort care; she died in the hosp
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vaccination failure
Clinical narrative: recently discharged from hospital for AHRF secondary to COVID; presented back to hosp with worsening dyspnea; treated with dexamethasone, antibiotics, redesivir; required intubation with mechanical ventilation; increased O2 requirements; pt transitioned to comfort care; she died in the hosp
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, Death, Dyspnoea, Endotracheal intubation
Clinical narrative: recently discharged from hospital for AHRF secondary to COVID; presented back to hosp with worsening dyspnea; treated with dexamethasone, antibiotics, redesivir; required intubation with mechanical ventilation; increased O2 requirements; pt transitioned to comfort care; she died in the hosp
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mechanical ventilation
Clinical narrative: recently discharged from hospital for AHRF secondary to COVID; presented back to hosp with worsening dyspnea; treated with dexamethasone, antibiotics, redesivir; required intubation with mechanical ventilation; increased O2 requirements; pt transitioned to comfort care; she died in the hosp
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Injection site pain, Paraesthesia, Paraesthesia oral
Clinical narrative: Tingling, numbness of the tongue, metallic taste in the mouth, severe lethargy, confusion
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Dysgeusia, Hypoaesthesia oral, Lethargy, Paraesthesia oral
Clinical narrative: Tingling, numbness of the tongue, metallic taste in the mouth, severe lethargy, confusion
Sex: F
Vaccine: MMR, MMR
Symptoms: Accidental exposure to product, No adverse event
Clinical narrative: not experiencing any additional side effects; Patient was inadvertently administered the MMR-Il vaccine instead of an MMR-Il titer test; This spontaneous report has been received from a health care professional referring to his 29 years old daughter. The patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies were not reported.  On 29-NOV-2021, the patient was inadvertently vaccinated with measles, mumps, and rubella (wistar RA 27-3) virus vaccine, live (M-M-R II) for prophylaxis instead of being performed an M-M-R II titer test (vaccination error) (lot number U006487 has been verified to be a valid lot number, the expiration date was reported and established as 26-FEB-2023; dose, vaccination scheme, route of administration and anatomical site of vaccination were not reported).  The reporter stated that he believed that the patient was not pregnant, but she was worried since she and her husband were trying to become pregnant. On 07-DEC-2021, the reporter had contacted Merck and informed that was measles, mumps, and rubella (wistar RA 27-3) virus vaccine, live (M-M-R II) was given inadvertently to the patient at new job and it was a medication error. The patient should wait for 28 days after the vaccine was administered. The reporter was requested to inform if the patient becomes pregnant within that time frame for follow up.  The patient was not experiencing any additional side effects (no adverse event). No further information was available.
Sex: F
Vaccine: MMR, MMR
Symptoms: No adverse event, Vaccination error
Clinical narrative: not experiencing any additional side effects; Patient was inadvertently administered the MMR-Il vaccine instead of an MMR-Il titer test; This spontaneous report has been received from a health care professional referring to his 29 years old daughter. The patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies were not reported.  On 29-NOV-2021, the patient was inadvertently vaccinated with measles, mumps, and rubella (wistar RA 27-3) virus vaccine, live (M-M-R II) for prophylaxis instead of being performed an M-M-R II titer test (vaccination error) (lot number U006487 has been verified to be a valid lot number, the expiration date was reported and established as 26-FEB-2023; dose, vaccination scheme, route of administration and anatomical site of vaccination were not reported).  The reporter stated that he believed that the patient was not pregnant, but she was worried since she and her husband were trying to become pregnant. On 07-DEC-2021, the reporter had contacted Merck and informed that was measles, mumps, and rubella (wistar RA 27-3) virus vaccine, live (M-M-R II) was given inadvertently to the patient at new job and it was a medication error. The patient should wait for 28 days after the vaccine was administered. The reporter was requested to inform if the patient becomes pregnant within that time frame for follow up.  The patient was not experiencing any additional side effects (no adverse event). No further information was available.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Asthenia, C-reactive protein normal, Computerised tomogram thorax abnormal, Deep vein thrombosis
Clinical narrative: pt prsented 3 days post vaccine with DVT and massive PE.  Also found to have cardiomyopathy with EF 30%
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Echocardiogram abnormal, Ejection fraction decreased, Electrocardiogram abnormal, Exercise tolerance decreased
Clinical narrative: pt prsented 3 days post vaccine with DVT and massive PE.  Also found to have cardiomyopathy with EF 30%
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Feeling cold, Heart rate increased, Incomplete course of vaccination, Inflammation
Clinical narrative: pt prsented 3 days post vaccine with DVT and massive PE.  Also found to have cardiomyopathy with EF 30%
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Left ventricular failure, Musculoskeletal chest pain, Pain, Pleuritic pain, Pulmonary embolism
Clinical narrative: pt prsented 3 days post vaccine with DVT and massive PE.  Also found to have cardiomyopathy with EF 30%
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, Ultrasound Doppler abnormal, Vaccination complication
Clinical narrative: pt prsented 3 days post vaccine with DVT and massive PE.  Also found to have cardiomyopathy with EF 30%
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cardiomyopathy, Computerised tomogram thorax abnormal, Deep vein thrombosis, Echocardiogram, Ejection fraction decreased
Clinical narrative: pt prsented 3 days post vaccine with DVT and massive PE.  Also found to have cardiomyopathy with EF 30%
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram, Electrocardiogram, Myocarditis, Troponin I
Clinical narrative: Per hospital records, on 12/24/2021, "Patient is a 19 year old male who presented to the ED with complaints of sore throat and chest discomfort. He had a Pfizer COVID booster vaccination 4 days ago then developed some body aches the following day. Those symptoms improved over the next day but today he began having some burning in his throat and chest area. The burning sensation began at about 7 am when he first woke up and was still present around 10 am. The sensation did not radiate and was not associated with any nausea, vomiting, dyspnea, palpitations, edema or dizziness. He denies recent heavy physical exertion. He has a history of depression. He denies smoking, vaping, ETOH or drug use. He denied fever, chills, cough, shortness of breath, abdominal pain, nausea vomiting or diarrhea. Currently he is not having any chest pain, burning, cough, or shortness of breath. In the ED, his temperature was 98.4 F, pulse 97, respirations 18, blood pressure 130/81, oxygen saturation 97% on room air. Labs revealed a white count of 7400, hemoglobin 14.3, hematocrit 41.8, platelets 215, high sensitive troponin I was elevated at 5790.9. Throat culture was negative for group A strep. SARS-CoV-2 PCR was negative. Influenza PCR negative and RSV PCR was negative. A 12 lead EKG revealed sinus tachycardia with a rate of 101. Normal AST T-wave  as read by the ER physician. He received some IV fluids and Cardiology was notified. As soon as the the patient was transferred to medical floor, patient had no chest pain, shortness of breath or palpitations. Troponin went up to 7610 and then trended down to 3554. Echocardiogram was done that showed normal ejection fraction with no valvular disease and wall motion abnormality. Repeated EKG is also negative for acute ischemic changes and showed normal sinus rhythm. Cardiology evaluated the patient again today and did recommend that patient could be discharged to home but he needs to have a follow-up echocardiogram. Discharge plan is discussed with the patient and he agrees with the plan".
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chest pain, Drug screen negative, Echocardiogram normal, Ejection fraction normal
Clinical narrative: Per hospital records, on 12/24/2021, "Patient is a 19 year old male who presented to the ED with complaints of sore throat and chest discomfort. He had a Pfizer COVID booster vaccination 4 days ago then developed some body aches the following day. Those symptoms improved over the next day but today he began having some burning in his throat and chest area. The burning sensation began at about 7 am when he first woke up and was still present around 10 am. The sensation did not radiate and was not associated with any nausea, vomiting, dyspnea, palpitations, edema or dizziness. He denies recent heavy physical exertion. He has a history of depression. He denies smoking, vaping, ETOH or drug use. He denied fever, chills, cough, shortness of breath, abdominal pain, nausea vomiting or diarrhea. Currently he is not having any chest pain, burning, cough, or shortness of breath. In the ED, his temperature was 98.4 F, pulse 97, respirations 18, blood pressure 130/81, oxygen saturation 97% on room air. Labs revealed a white count of 7400, hemoglobin 14.3, hematocrit 41.8, platelets 215, high sensitive troponin I was elevated at 5790.9. Throat culture was negative for group A strep. SARS-CoV-2 PCR was negative. Influenza PCR negative and RSV PCR was negative. A 12 lead EKG revealed sinus tachycardia with a rate of 101. Normal AST T-wave  as read by the ER physician. He received some IV fluids and Cardiology was notified. As soon as the the patient was transferred to medical floor, patient had no chest pain, shortness of breath or palpitations. Troponin went up to 7610 and then trended down to 3554. Echocardiogram was done that showed normal ejection fraction with no valvular disease and wall motion abnormality. Repeated EKG is also negative for acute ischemic changes and showed normal sinus rhythm. Cardiology evaluated the patient again today and did recommend that patient could be discharged to home but he needs to have a follow-up echocardiogram. Discharge plan is discussed with the patient and he agrees with the plan".